-
Most Recent
Search Results
240 results for CELG
4 Reasons Celgene Is the Real Deal
Celgene has reached all-time highs in the wake of the firm’s boffo reviews at this week’s JPMorgan Healthcare Conference … and it’s still worth buying.
At $96.14, Celgene (CELG) a Sell
Celgene (CELG) remains a Sell this week based on the most current comparative pricing of its shares and stock market rankings.
CELG: The Next Biotech Stock to Go Boom
CELG stock is just now attempting to break out of a multi-month ascending triangle. Double your money in CELG stock with this option trade.
Spread the Love With CELG Stock Options
Celgene has drawn the favor of several analysts of late, but right now it’s the charts that make this options trade on CELG stock look…
Celgene (CELG) a Sell on Slumping Quant Score
Celgene Corp (NASDAQ:CELG) is a constituent of the 349 company Biotechnology GICS industry group, which is a segment of the 781 company GICS Health Care…
Celgene (CELG) a Strong Sell at $91.56
Celgene (CELG) a Strong Sell this week based on the most recent stock market rankings, and comparative pricing of its shares.
Why Celgene Corporation Stock Is ALL About the Buyouts
For CELG stock, traders are going focus on its pipeline and nothing else. With that in mind, here’s what Celgene’s longer-term prospects look like.
Celgene (CELG) a Sell on Flagging Quant Score
The current recommendation of Sell for Celgene Corp (NASDAQ:CELG) has been derived by using Louis Navellier’s investing methodology and his Portfolio Grader stock evaluator. The…
4 Reasons to Own Celgene Corporation (CELG) Stock
There are four big reasons why Celgene (CELG) stock is the best big biotech stock to buy and hold for the next decade.
Weakening Earnings Visibility Downgrades Celgene (CELG) to Hold
Celgene Corp (NASDAQ:CELG) is classified as a constituent of the 345 company Biotechnology GICS industry group, which is a segment of the 782 company GICS…
Here’s Why You Should Buy More CELG Shares After Earnings Dip
Third quarter show that CELG continues to grow its business, it continues to make product people like and that Revlimid hasn’t peaked yet.
This week, Celgene (CELG) a Strong Sell
At $89.04, Celgene (CELG) a Strong Sell based on the most recent relative pricing of its shares and market intelligence.
Celgene Corporation: Use This Bullish Play to Maximize Profit (CELG)
Use a CELG vertical to win some solid upside in Celgene stock.
Lackluster Earnings Visibility Drop Celgene (CELG) to Sell
Celgene Corp (NASDAQ:CELG) is ranked as a Sell using Louis Navellier’s investing system and his Portfolio Grader stock evaluator. The shares have been downgraded from…
Sinking Industry Group Rank Keep Celgene (CELG) a Sell
With a $80.4 billion market value, Celgene Corp (NASDAQ:CELG) ranks in the top decile in its industry group, Biotechnology, and in the top decile of…
Celgene Corporation (CELG) Stock Is Staging a Tempting Breakout
CELG looks ready to follow-through, but you can smartly contain some of that optimism in Celgene with this play.
Fewer Negatives Lift Ranking of Celgene (CELG) to Hold
With a $83.5 billion market value, Celgene Corp (NASDAQ:CELG) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of…
Inferior Industry Group Rank Drop Celgene (CELG) to Sell
Portfolio Grader currently ranks Celgene Corp (NASDAQ:CELG) a Sell. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier…
CELG Stock – Here’s Why Celgene Is Worth Snapping Up
CELG stock has soared over the last year, but it looks ready to break out after a rare breather. Investors should buy into Celgene now,…
Why Celgene Corporation (CELG) Can Finish 2016 in the Black
With Celgene’s increased guidance and a strong pipeline, CELG stock looks undervalued at current prices.
Celgene Corporation: Why CELG Stock Could Top $200/Share
CELG stock’s upside between now and the next 10 years make Celgene one of the best investments in the market.
2018 Should Be Better for Celgene Corporation and CELG Stock
CELG stock suffered in 2017 after some disappointing news, but Celgene has set the stage for a much better 2018. Here’s what to look for.
Trade of the Day: Buy CELG Stock Now or Wait for a Pullback?
Biotech favorite Celgene Corporation is up more than 25% since mid-October. See my target on CELG stock.
2 – 10 of 240 results
